- Home
- UNCY vs ACFN Comparison
UNCY vs ACFN Comparison
Compare UNCY & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- ACFN
- Stock Information
- Founded
- UNCY 2016
- ACFN 1986
- Country
- UNCY United States
- ACFN United States
- Employees
- UNCY N/A
- ACFN N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- ACFN Military/Government/Technical
- Sector
- UNCY Health Care
- ACFN Consumer Discretionary
- Exchange
- UNCY Nasdaq
- ACFN Nasdaq
- Market Cap
- UNCY 74.2M
- ACFN 61.9M
- IPO Year
- UNCY 2021
- ACFN N/A
- Fundamental
- Price
- UNCY $4.42
- ACFN $14.17
- Analyst Decision
- UNCY Strong Buy
- ACFN
- Analyst Count
- UNCY 5
- ACFN 0
- Target Price
- UNCY $41.60
- ACFN N/A
- AVG Volume (30 Days)
- UNCY 459.6K
- ACFN 20.5K
- Earning Date
- UNCY 11-14-2025
- ACFN 11-06-2025
- Dividend Yield
- UNCY N/A
- ACFN N/A
- EPS Growth
- UNCY N/A
- ACFN 1520.82
- EPS
- UNCY N/A
- ACFN 2.84
- Revenue
- UNCY N/A
- ACFN $13,202,000.00
- Revenue This Year
- UNCY N/A
- ACFN N/A
- Revenue Next Year
- UNCY $19,392.60
- ACFN N/A
- P/E Ratio
- UNCY N/A
- ACFN $8.11
- Revenue Growth
- UNCY N/A
- ACFN 50.98
- 52 Week Low
- UNCY $3.71
- ACFN $12.42
- 52 Week High
- UNCY $11.00
- ACFN $33.00
- Technical
- Relative Strength Index (RSI)
- UNCY 43.93
- ACFN 18.83
- Support Level
- UNCY $4.32
- ACFN $12.50
- Resistance Level
- UNCY $4.63
- ACFN $24.16
- Average True Range (ATR)
- UNCY 0.29
- ACFN 1.87
- MACD
- UNCY -0.08
- ACFN -1.01
- Stochastic Oscillator
- UNCY 12.61
- ACFN 11.48
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.